At BELLUS, we are focused on advancing novel therapeutics for conditions with high unmet medical need. Read More

At BELLUS, we are focused on advancing novel therapeutics for conditions with high unmet medical need. Read More

Blog

May 31, 2017 Understanding Chronic Cough
As part of our chronic cough program’s due diligence process, we interviewed many clinician experts in the field who identified chronic cough as an area with high unmet medical need. Not only does chronic cough affect a large proportion of the population - about 10% of adults in most industrialized countries - but there is a large percentage of highly underserved patients (10-40% 1,2 ) that...
Read More
April 12, 2017 CEO Message to Shareholders (from 2016 Annual Report)
DearShareholders, It’s remarkable the difference one year can make. I’d like to tell you how we felt upon learning of the negative KIACTATM Phase 3 AA amyloidosis results in mid 2016, how we decided to rebuild from this bitter disappointment and why we are more excited than ever about the future-particularly because of our new project, BLU-5937. Shocked and disappointed. From our partners at...
Read More

Share this

Sign up for email alerts

Email Address *
 
Enter the code shown above.